PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.
about
PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
PDE5 Inhibitor Tadalafil and H ...... Myocardial Infarction in Mice.
@en
type
label
PDE5 Inhibitor Tadalafil and H ...... Myocardial Infarction in Mice.
@en
prefLabel
PDE5 Inhibitor Tadalafil and H ...... Myocardial Infarction in Mice.
@en
P2860
P356
P1476
PDE5 Inhibitor Tadalafil and H ...... Myocardial Infarction in Mice.
@en
P2093
Rakesh C Kukreja
P2860
P356
10.1124/JPET.116.239087
P407
P50
P577
2017-01-25T00:00:00Z